MX362435B - Novedoso sistema farmaceutico de entrega bifasica para el tratamiento del dolor y la inflamacion. - Google Patents
Novedoso sistema farmaceutico de entrega bifasica para el tratamiento del dolor y la inflamacion.Info
- Publication number
- MX362435B MX362435B MX2013008996A MX2013008996A MX362435B MX 362435 B MX362435 B MX 362435B MX 2013008996 A MX2013008996 A MX 2013008996A MX 2013008996 A MX2013008996 A MX 2013008996A MX 362435 B MX362435 B MX 362435B
- Authority
- MX
- Mexico
- Prior art keywords
- tablet
- inflammation
- treating pain
- novel pharmaceutical
- biphasic delivery
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
- A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Abstract
La presente invención se refiere a composiciones farmacéuticas estables que comprenden un sistema tableta-tableta que consiste en la compresión de una tableta dentro de otra tableta con un sistema de entrega bifásica de al menos un análogo del (1R,2R)-rel-2-[(Dimetilamino)metil]-1-(3-metoxifenil) ciclohexanol (Tramadol) y/o sus sales farmacéuticamente aceptables y/o un análogo del 2-[(2,6-Diclorofenii)amino]benceneac etico ácido carboximetilester (Aceclofenaco) y/o sus sales farmacéuticamente estables contenidos en la tableta. Dichas composiciones son útiles para el control y/o prevención y/o tratamiento del dolor agudo y/o crónico así como la inflamación aguda y/o crónica.
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
MX2013008996A MX362435B (es) | 2013-08-02 | 2013-08-02 | Novedoso sistema farmaceutico de entrega bifasica para el tratamiento del dolor y la inflamacion. |
PCT/MX2014/000114 WO2015016695A1 (es) | 2013-08-02 | 2014-07-24 | Novedoso sistema farmacéutico de entrega bifásica para el tratamiento del dolor y la inflamación |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
MX2013008996A MX362435B (es) | 2013-08-02 | 2013-08-02 | Novedoso sistema farmaceutico de entrega bifasica para el tratamiento del dolor y la inflamacion. |
Publications (2)
Publication Number | Publication Date |
---|---|
MX2013008996A MX2013008996A (es) | 2014-03-24 |
MX362435B true MX362435B (es) | 2019-01-17 |
Family
ID=50935221
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2013008996A MX362435B (es) | 2013-08-02 | 2013-08-02 | Novedoso sistema farmaceutico de entrega bifasica para el tratamiento del dolor y la inflamacion. |
Country Status (2)
Country | Link |
---|---|
MX (1) | MX362435B (es) |
WO (1) | WO2015016695A1 (es) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101710792B1 (ko) * | 2015-07-14 | 2017-02-28 | 주식회사 유영제약 | 세레콕시브 및 트라마돌을 함유하는 약제학적 조성물 |
CN110141531B (zh) * | 2019-06-06 | 2022-04-19 | 周大凯 | 一种包裹活性组分的组合物及其应用 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BRPI0708640A8 (pt) * | 2006-03-06 | 2018-04-24 | Pozen Inc | composição farmacêutica, e, métodos para tratar um paciente com dor de cabeça de enxaqueca, para tratar um paciente com dor e para tratar um paciente com enxaqueca |
US8765178B2 (en) * | 2006-07-19 | 2014-07-01 | Watson Laboratories, Inc. | Controlled release formulations and associated methods |
US20080026054A1 (en) * | 2007-04-27 | 2008-01-31 | Nectid Inc. | Novel anelgesic combination |
KR101972299B1 (ko) * | 2007-11-23 | 2019-08-16 | 그뤼넨탈 게엠베하 | 타펜타돌 조성물 |
-
2013
- 2013-08-02 MX MX2013008996A patent/MX362435B/es active IP Right Grant
-
2014
- 2014-07-24 WO PCT/MX2014/000114 patent/WO2015016695A1/es active Application Filing
Also Published As
Publication number | Publication date |
---|---|
MX2013008996A (es) | 2014-03-24 |
WO2015016695A1 (es) | 2015-02-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1123460T1 (el) | Ενωσεις και μεθοδοι για τη θεραπεια μιας επιληπτικης διαταραχης | |
EA201691454A1 (ru) | Композиции придопидина модифицированного высвобождения | |
JP2012193216A5 (es) | ||
EA201270221A1 (ru) | Лечение болезни крона с применением лаквинимода | |
PH12015500375A1 (en) | Nep inhibitors for treating diseases characterized by atrial enlargemenet or remodeling | |
EA201491285A1 (ru) | Улучшенные композиции и способы доставки омепразола и ацетилсалициловой кислоты | |
WO2014205229A8 (en) | Use of high dose pridopidine for treating huntington's disease | |
PH12021551189A1 (en) | Cholix toxin-derived fusion molecules for oral delivery of biologically active cargo | |
AR090491A1 (es) | Tratamiento de la esclerosis multiple con una combinacion de laquinimod y fumarato de dimetilo | |
WO2011127333A3 (en) | Compounds for treating disease, for administering, and for pharmaceutical compositions | |
WO2012048294A3 (en) | Pharmaceutical compositions for treating chronic pain and pain associated with neuropathy | |
EP3300734A3 (en) | Use of levocetirizine and montelukast in the treatment of autoimmune disorders | |
AR093182A1 (es) | Metodo para tratar el sobrepeso o la obesidad | |
WO2015079010A3 (en) | Pharmaceutical composition comprising lacosamide and levetiracetam | |
IN2015DN01023A (es) | ||
EA201501164A1 (ru) | Твердая фармацевтическая лекарственная форма | |
EA202090637A1 (ru) | Способы применения дипивефрина | |
EP3309555A3 (en) | Methods for preventing or treating disorders by increasing bioavailability of iron and related pharmaceutical formulation | |
MX2013008996A (es) | Novedoso sistema farmaceutico de entrega bifasica para el tratamiento del dolor y la inflamacion. | |
GR1008228B (el) | Φαρμακευτικο σκευασμα περιεχον ενα διπλο αναστολεα επαναπροσληψης και μεθοδος για την παρασκευη αυτου | |
MX366309B (es) | Composicion farmaceutica para el tratamiento de inflamacion y dolor. | |
TW201129361A (en) | Methods for treating pain | |
HRP20211309T1 (hr) | N,n-bis-2-merkaptoetil izoftalamid za liječenje parkinsonove bolesti | |
MX2016003979A (es) | Metodo para profilaxis o tratamiento de lupus eritematoso sistemico y/o nefritis lupica. | |
WO2015166418A3 (es) | Composición farmacéutica para el tratamiento de alopatías relacionadas con el dolor, usando como agente activo al ketorolaco trometamina y clorhidrato de tramadol |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant or registration |